Will the Phase 3 trial "The Role of Peripheral Afferents in Modulating Post-stroke Central Pain" reach primary completion on or before Sep 8, 2026?

Resolves Yes if ClinicalTrials.gov record NCT06446960 (Institut National de la Santé Et de la Recherche Médicale, France) shows an actual primary completion date on or before Sep 8, 2026. Registered date at generation: Sep 8, 2026.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Sep 8, 2026, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.